MBXBF (Microbix Biosystems) Enterprise Value: $28.57 Mil (As of Jun. 26, 2026) ***


MBXBF Microbix Biosystems Inc MBXBF
55 GF Score
Price $0.21
GF Value $0.17
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Microbix Biosystems Enterprise Value?

Microbix Biosystems MBXBF 55 Enterprise Value is $28.57 Mil as of Jun. 26, 2026. GuruFocus rates MBXBF with a GF Score™ of 55/100 and a GF Value™ of $0.17 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Microbix Biosystems's Enterprise Value is $28.57 Mil. Microbix Biosystems's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-3.49 Mil. Therefore, Microbix Biosystems's EV-to-EBIT ratio for today is -8.18.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Microbix Biosystems's Enterprise Value is $28.57 Mil. Microbix Biosystems's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-2.16 Mil. Therefore, Microbix Biosystems's EV-to-EBITDA ratio for today is -13.25.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Microbix Biosystems's Enterprise Value is $28.57 Mil. Microbix Biosystems's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $10.77 Mil. Therefore, Microbix Biosystems's EV-to-Revenue ratio for today is 2.65.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Microbix Biosystems's Enterprise Value is $28.57 Mil. Microbix Biosystems's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $-3.46 Mil. Therefore, Microbix Biosystems's EV-to-OCF ratio for today is -8.26.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Microbix Biosystems's Enterprise Value is $28.57 Mil. Microbix Biosystems's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.00 Mil. Therefore, Microbix Biosystems's EV-to-FCF ratio for today is -7.15.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Microbix Biosystems  (OTCPK:MBXBF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Microbix Biosystems's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=28.572/-3.491
=-8.18

Microbix Biosystems's current Enterprise Value is $28.57 Mil.
Microbix Biosystems's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.49 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Microbix Biosystems's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=28.572/-2.156
=-13.25

Microbix Biosystems's current Enterprise Value is $28.57 Mil.
Microbix Biosystems's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.16 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Microbix Biosystems's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=28.572/10.766
=2.65

Microbix Biosystems's current Enterprise Value is $28.57 Mil.
Microbix Biosystems's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.77 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Microbix Biosystems's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=28.572/-3.457
=-8.26

Microbix Biosystems's current Enterprise Value is $28.57 Mil.
Microbix Biosystems's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.46 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Microbix Biosystems's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=28.572/-3.997
=-7.15

Microbix Biosystems's current Enterprise Value is $28.57 Mil.
Microbix Biosystems's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microbix Biosystems Enterprise Value Related Terms


Microbix Biosystems Enterprise Value Historical Data

* Premium members only.

The historical data trend for Microbix Biosystems's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbix Biosystems Enterprise Value Chart

Microbix Biosystems Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.15 46.10 27.91 29.54 22.40

Microbix Biosystems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.08 26.49 22.40 22.55 22.65

MBXBF vs VRTX, REGN, ALNY: Enterprise Value Comparison

For the Biotechnology subindustry, Microbix Biosystems's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbix Biosystems Enterprise Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Enterprise Value falls into.


MBXBF
55GF Score
Microbix Biosystems Inc MBXBF
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbix Biosystems Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Microbix Biosystems's Enterprise Value for the fiscal year that ended in Sep. 2025 is calculated as

Microbix Biosystems's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of $28.57 Mil mean?
Microbix Biosystems (MBXBF) has a Enterprise Value of $28.57 Mil as of Jun. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Microbix Biosystems and its competitors.
Is Microbix Biosystems' Enterprise Value too high?
Microbix Biosystems' current Enterprise Value is $28.57 Mil. Overall, Microbix Biosystems has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Microbix Biosystems' Enterprise Value compare to VRTX and REGN?
Microbix Biosystems' Enterprise Value of $28.57 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Microbix Biosystems and its competitors. Microbix Biosystems's current Enterprise Value is $28.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbix Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Microbix Biosystems (MBXBF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.17, compared to a current price of $0.21 — trading 23.5% above its estimated fair value. The current Enterprise Value is $28.57 Mil. Microbix Biosystems' overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Microbix Biosystems (MBXBF), the current Enterprise Value is $28.57 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbix Biosystems (MBXBF) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of $0.21 is trading 23.5% above its estimated GF Value™ of $0.17. GuruFocus considers Microbix Biosystems to be Modestly Overvalued.

Key valuation signals for MBXBF:

  • Enterprise Value: $28.57 Mil
  • GF Value™: $0.17 vs. price of $0.21 (23.5% above fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the MBXBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Microbix Biosystems Business Description

Other Exchanges MBX:Canada
Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
55GF Score

Get the complete analysis for MBXBF

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price
$0.17
GF Value